immunology companies

Companies whose enriched business profile is tagged “immunology”, drawn from their SEC filings + website text. Sorted by market capitalization; every figure is delayed data from SEC EDGAR + market data, shown with its as-of date.

• Lilly (Eli) (LLY) Health Care — Eli Lilly is a global pharmaceutical innovator leading the market in metabolic health, including diabetes and obesity treatments, alongside a diverse portfolio of oncology and immunology therapies. ask →
• AbbVie (ABBV) Health Care — A diversified global biopharmaceutical leader with a strong footprint in immunology, neuroscience, and aesthetics, supported by a pipeline expanding into obesity. ask →
• NOVARTIS AG (NVS) Health Care — Novartis is a leading global pharmaceutical company focused on discovering and developing innovative, high-efficacy medicines across oncology, immunology, and neuroscience. ask →
• ASTRAZENECA PLC (AZN) Health Care — AstraZeneca is a global, science-led biopharmaceutical company focused on transforming patient outcomes in oncology, rare diseases, and chronic conditions through a robust and diverse R&D pipeline. ask →
• Pfizer (PFE) Health Care — A diversified, global biopharmaceutical giant focused on discovering and commercializing life-changing medicines, vaccines, and advanced therapies across key therapeutic areas. ask →
• APOGEE THERAPEUTICS INC (APGE) Health Care — Apogee Therapeutics is a clinical-stage biotechnology firm developing advanced biologic therapies for inflammatory and immunology diseases, currently pending acquisition by AbbVie. ask →
• KYMERA THERAPEUTICS INC (KYMR) Health Care — Kymera Therapeutics is pioneering oral, targeted protein degradation medicines designed to deliver biologic-like efficacy for underserved patients in immunology and beyond. ask →
• KINIKSA PHARMACEUTICALS INTERNATIO (KNSA) Health Care — Kiniksa is a biopharmaceutical company developing and commercializing therapies for chronic inflammatory and autoimmune diseases, with a pipeline featuring novel treatments for recurrent pericarditis. ask →
• ALUMIS INC (ALMS) Health Care — Alumis is a clinical-stage biopharmaceutical company developing targeted TYK2 inhibitors to transform the treatment of immune-mediated and neurodegenerative diseases. ask →
• NURIX THERAPEUTICS INC (NRIX) Health Care — Clinical-stage biotech pioneering AI-powered targeted protein degradation medicines for cancer and autoimmune diseases, with Phase 2 lead candidate bexobrutideg in CLL and partnerships spanning Roche, Gilead, and Sanofi. ask →
• BIOHAVEN LTD (BHVN) Health Care — Biohaven is a biopharmaceutical firm developing a diverse pipeline of innovative therapies for complex diseases in neuroscience, immunology, obesity, and oncology. ask →
• NEKTAR THERAPEUTICS (NKTR) Health Care — Nektar Therapeutics is a clinical-stage biotechnology company developing first-in-class immunomodulatory therapies aimed at restoring immune system balance to treat chronic autoimmune and inflammatory disorders. ask →
• AVALO THERAPEUTICS INC (AVTX) Health Care — A clinical-stage biotechnology company developing targeted monoclonal antibody therapies for immunology and inflammatory conditions. ask →
• IMMIX BIOPHARMA INC (IMMX) Health Care — Immix Biopharma is a clinical-stage biopharmaceutical company developing novel therapeutic candidates to address critical unmet needs in oncology and inflammatory disease treatment. ask →
• ZURA BIO LTD CLASS A (ZURA) Health Care — Zura Bio is a clinical-stage biotechnology company pioneering bispecific antibody therapies to address significant unmet needs in complex autoimmune and inflammatory diseases. ask →
• KYVERNA THERAPEUTICS INC (KYTX) Health Care — Kyverna Therapeutics is a late-stage clinical company developing potentially curative CAR T-cell therapies for patients with severe neurologic autoimmune diseases. ask →
• ENANTA PHARMACEUTICALS INC (ENTA) Health Care — Enanta Pharmaceuticals is a clinical-stage biotechnology company developing oral, small-molecule therapies for RSV and immunological diseases, supported by ongoing hepatitis C royalty revenues. ask →
• TONIX PHARMACEUTICALS HOLDING CORP (TNXP) Health Care — A commercial-stage biopharmaceutical company focused on CNS, immunology, and infectious disease therapies, headlined by its FDA-approved fibromyalgia treatment, TONMYA. ask →
• Aldeyra Therapeutics, Inc. (ALDX) Health Care — Biotechnology company developing novel RASP-modulating therapies to treat immune-mediated inflammatory diseases, with a lead focus on ocular health. ask →

Not quite it? Describe exactly what you want →

Data: SEC EDGAR (filings) + market data (fundamentals, delayed daily-close). Figures shown with their as-of date.

Last updated 2026-10-08.

Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date.